GENFLOW BIOSCIENCES PLC (WQ5) — Cash Flow-to-Debt Ratio
GENFLOW BIOSCIENCES PLC (WQ5) has a Cash Flow-to-Debt Ratio of -1.37x as of December 2024, meaning its operating cash flow of €-1.08 Million could theoretically repay -1% of its total liabilities (€788.92K) in one year. See GENFLOW BIOSCIENCES PLC working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
GENFLOW BIOSCIENCES PLC Cash Flow-to-Debt Ratio (2021–2024)
Historical debt coverage capacity for GENFLOW BIOSCIENCES PLC across 4 annual periods. Also explore how fast is GENFLOW BIOSCIENCES PLC growing its equity to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for GENFLOW BIOSCIENCES PLC (2021–2024)
Year-by-year debt coverage analysis for GENFLOW BIOSCIENCES PLC. For market capitalisation and broader financial context, see WQ5 market cap.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -1.37x | €-1.08 Million | €788.92K | ▲ +52.8% |
| 2023 | -2.90x | €-1.66 Million | €571.96K | ▲ +46.7% |
| 2022 | -5.45x | €-1.37 Million | €250.99K | ▼ -61.5% |
| 2021 | -3.38x | €-747.38K | €221.43K | — |